Kyle Konze

Kyle Konze, PhD, is a Senior Principal Scientist at Schrödinger, specializing in small molecule structure-based drug design. Trained as a medicinal chemist, Kyle's dissertation research focused on designing and synthesizing novel chemical probes for lysine methyltransferases. Previously, Kyle held various roles within Schrödinger, contributing to drug discovery programs by leveraging advanced technologies to advance projects into clinical phases. Kyle's early research experience included roles as an undergraduate research assistant at the University of Minnesota and the University of North Carolina at Chapel Hill, where they gained skills in plant biology, molecular biology, and computer-aided drug design.